This article is more than 5 years old. Information may no longer be current.
Barbara Ann Karmanos Cancer Institute appoints associate director
Elisabeth Heath, MD, FACP, has been named associate center director for translational sciences at Barbara Ann Karmanos Cancer Institute.
Heath will enhance translational research, facilitate communication and interactions between scientists and clinicians, and assemble teams of scientists and clinicians for major research grants.
“It’s critical that we, as scientific leaders, work together to move promising cancer research from the lab to the clinic, and — with the resources and evidence-based findings — share innovative treatments with the community,” Heath said in a press release. “Enhancing the patient’s understanding of clinical trials and improving access to innovative treatments through trial enrollment is the driving force to develop new cancer treatments. I’m excited to accept this new role and work with our incredibly talented team of committed scientists to achieve best practices that lead to increased patient survival.”
Heath, a member of Karmanos since 2003, will continue to lead its genitourinary oncology multidisciplinary team. She also will continue to serve as medical director of the infusion center, director of prostate cancer research and the endowed chair for prostate cancer research.
“Dr. Heath — with her expertise, strategic abilities, proactive communication style and proven results — continues to advocate for and advance cancer research while engaging other scientists, physicians and constituents,” Gerold Bepler, MD, PhD, president and CEO of Karmanos Cancer Institute, said in the press release. “She is driven and committed to develop solutions for this complicated disease. It’s at the heart of everything she does so that more people survive cancer and thrive. This — and her ability to excite, engage and retain talent — makes her an excellent choice for this leadership position.”